4th Quarter - Amendment

MERCK & CO, INC. for MERCK & CO INC

Firm
Client
Income
—
Expenses
$490,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2015 $460,000 Replaced
4th Quarter - Amendment (this page) Mar 25, 2015 $490,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual property (general education, no specific bill), patent reform (general education, no specific bill)

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —
ELI JOSEPH —
KATIE OPPENHEIM —
ANGELA M STEWART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Comprehensive tax reform (no specific bill), orphan drug tax credit (S.1128), R&D tax credit (no specific bill), base erosion (no specific bill), territorial tax system (no specific bill)

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —
ELI JOSEPH —
ERIN POLAK —
ANGELA M STEWART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1128 (113th)

Health Issues HCR

340B (no specific bill), National Diabetes Clinical Care Commission Act (H.R. 1074, S.539), Eliminating Disparities in Diabetes Prevention Act (H.R. 3322), Oncology education (no specific bill), adult vaccine policies (no specific bill), medication adherence, DISARM (H.R. 4187), ACA Implementation (no specific bill), Hepatitis C education (no specific bill), HIV education (no specific bill), MODDERN Cures Act of 2013 (H.R. 3116), biosimilars (no specific bill), Alzheimer's education (no specific bill)21st Century Cures (no specific bill), general pharmaceutical industry issues and education

LobbyistCovered position, as disclosed
ERIN DARLING —
ROBERT FILIPPONE —
ELI JOSEPH —
PATRICK LIEDTKA —
JEROME MURRAY —
KATIE OPPENHEIM —
ERIN POLAK —
ANGELA M STEWART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3116 (113th), H.R. 4187 (113th), H.R. 1074 (113th), S. 539 (113th), H.R. 3322 (113th)

Medicare/Medicaid MMM

Medicare Part D (general education, no specific bill), changes to low-income subsidy structure in Medicare Part D (general education, no specific bill), sustainable growth rate (general education, no specific bill), Medicare Part B (general education, no specific bill), Preserving the Integrity of Medicare Act (H.R. 5780)

LobbyistCovered position, as disclosed
ERIN DARLING —
ROBERT FILIPPONE —
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM —
ERIN POLAK —
ANGELA M STEWART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5780 (113th)

Budget/Appropriations BUD

General budget issues (no specific bill), budget reconciliation (no specific bill)

LobbyistCovered position, as disclosed
ROBERT FILIPPONE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Education on beta-agonists (no specific bill), education on antibiotics and veterinary biologics (no specific bill)

LobbyistCovered position, as disclosed
ERIN POLAK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.